KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adient (ADNT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Adient (ADNT) over the last 11 years, with Q4 2025 value amounting to $78.7 million.

  • Adient's Shares Outstanding (Weighted Average) fell 675.36% to $78.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $78.7 million, marking a year-over-year decrease of 675.36%. This contributed to the annual value of $83.0 million for FY2025, which is 726.26% down from last year.
  • As of Q4 2025, Adient's Shares Outstanding (Weighted Average) stood at $78.7 million, which was down 675.36% from $83.0 million recorded in Q3 2025.
  • Adient's Shares Outstanding (Weighted Average)'s 5-year high stood at $95.3 million during Q1 2023, with a 5-year trough of $78.7 million in Q4 2025.
  • For the 5-year period, Adient's Shares Outstanding (Weighted Average) averaged around $91.0 million, with its median value being $94.2 million (2021).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first skyrocketed by 63.83% in 2021, then tumbled by 914.96% in 2024.
  • Adient's Shares Outstanding (Weighted Average) (Quarter) stood at $94.6 million in 2021, then increased by 0.53% to $95.1 million in 2022, then fell by 2.31% to $92.9 million in 2023, then fell by 9.15% to $84.4 million in 2024, then decreased by 6.75% to $78.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $78.7 million for Q4 2025, versus $83.0 million for Q3 2025 and $83.9 million for Q2 2025.